Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 16:01 | 14 Jul | 632.20 |
-5.95 (-0.93%) |
OPEN
640.00 |
HIGH
644.00 |
LOW
631.45 |
| NSE 15:59 | 14 Jul | 632.30 |
-6.05 (-0.95%) |
OPEN
639.95 |
HIGH
644.00 |
LOW
631.25 |
| OPEN | 640.00 |
| PREVIOUS CLOSE | 638.15 |
| VOLUME | 499229 |
| 52-Week high | 696.00 |
| 52-Week low | 356.75 |
| P/E | 21.99 |
| Mkt Cap.(Rs cr) | 50,971 |
| Buy Price | 632.20 |
| Buy Qty | 55.00 |
| Sell Price | 633.00 |
| Sell Qty | 72.00 |
Cipla Ltd. (CIPLA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Dr Reddy's Labs | 3983.45 | 84.85 | 2.18 | 2937.70 |
| Cipla | 632.20 | -5.95 | -0.93 | 1888.41 |
| Glenmark Pharma. | 407.05 | -8.40 | -2.02 | 1622.11 |
| Cadila Health. | 353.70 | -4.50 | -1.26 | 1602.10 |
| Lupin | 872.30 | 3.00 | 0.35 | 1538.83 |
| Aurobindo Pharma | 809.65 | 0.45 | 0.06 | 1529.73 |
| Divi's Lab. | 2212.60 | -22.65 | -1.01 | 1332.65 |
| Alembic Pharma | 945.00 | 1.10 | 0.12 | 969.40 |
| Torrent Pharma. | 2420.25 | 60.35 | 2.56 | 938.51 |
| P & G Health Ltd | 4051.35 | -56.30 | -1.37 | 838.72 |
| Sun Pharma.Inds. | 491.95 | -7.70 | -1.54 | 816.60 |
| Alkem Lab | 2494.85 | 90.15 | 3.75 | 799.84 |
| Natco Pharma | 672.35 | -6.80 | -1.00 | 667.10 |
| Ipca Labs. | 1652.35 | 10.20 | 0.62 | 454.91 |
| Abbott India | 15284.70 | -238.25 | -1.53 | 450.33 |
| Ajanta Pharma | 1360.40 | -29.00 | -2.09 | 441.13 |
| Biocon | 437.45 | 22.85 | 5.51 | 440.90 |
| Pfizer | 4182.00 | 48.80 | 1.18 | 429.05 |
| Sanofi India | 7674.75 | 57.60 | 0.76 | 414.20 |
| Syngene Intl. | 420.20 | -15.45 | -3.55 | 411.50 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
